QPIAI PHARMA Trademark

Trademark Overview


On Thursday, March 5, 2026, a trademark application was filed for QPIAI PHARMA with the United States Patent and Trademark Office. The USPTO has given the QPIAI PHARMA trademark a serial number of 99684396. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, March 5, 2026. This trademark is owned by QpiAI India Pvt Ltd.. The QPIAI PHARMA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence for data exploration; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence for developing data science models; Providing temporary use of online non-downloadable software development kits (SDKs); Virtual testing of new product designs using computer simulations; Platform as a service (PAAS) featuring computer software platforms for quantum computing; Providing temporary use of online non-downloadable simulation software for modeling in the pharmaceutical industry; Providing temporary use of on-line non-downloadable software for molecular modeling and chemical reaction simulation; Development of computer programs for simulating laboratory experiments; Scientific research in the field of computational chemistry and drug discovery; Software as a service (SAAS) services featuring software for drug discovery; Pharmaceutical products develop...

General Information


Serial Number99684396
Word MarkQPIAI PHARMA
Filing DateThursday, March 5, 2026
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, March 5, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkQPIAI PHARMACEUTICAL
Pseudo MarkQPI AI PHARMACEUTICALS
Goods and ServicesArtificial intelligence as a service (AIAAS) services featuring software using artificial intelligence for data exploration; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence for developing data science models; Providing temporary use of online non-downloadable software development kits (SDKs); Virtual testing of new product designs using computer simulations; Platform as a service (PAAS) featuring computer software platforms for quantum computing; Providing temporary use of online non-downloadable simulation software for modeling in the pharmaceutical industry; Providing temporary use of on-line non-downloadable software for molecular modeling and chemical reaction simulation; Development of computer programs for simulating laboratory experiments; Scientific research in the field of computational chemistry and drug discovery; Software as a service (SAAS) services featuring software for drug discovery; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research in the field of quantum computing
Pseudo MarkQPI ARTIFICIAL INTELLIGENCE PHARMACEUTICALS
Pseudo MarkQPI AI PHARMACEUTICAL
Pseudo MarkQPI AI PHARMA
Pseudo MarkQPI ARTIFICIAL INTELLIGENCE PHARMA
Pseudo MarkQPI ARTIFICIAL INTELLIGENCE PHARMACEUTICAL
Pseudo MarkQPIAI PHARMACEUTICALS

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, March 5, 2026
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameQpiAI India Pvt Ltd.
Party Type10 - Original Applicant
Legal Entity Type24 - NOT AVAILABLE
AddressBengaluru 560045
IN

Trademark Events


Event DateEvent Description
Thursday, March 5, 2026NEW APPLICATION ENTERED
Thursday, March 5, 2026APPLICATION FILING RECEIPT MAILED